<DOC>
	<DOCNO>NCT00503217</DOCNO>
	<brief_summary>The aim study ass whether GnRH agonist administration luteal phase improve pregnancy outcome intrauterine insemination ( IUI ) cycle .</brief_summary>
	<brief_title>GnRH Agonist Intrauterine Insemination</brief_title>
	<detailed_description />
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Women &lt; 38 year old Bilateral tubal patency confirm hysterosonography Normal ultrasound scan uterus ovary Normal day 3 basal hormone Motile sperm count capacitation ≥ 3 mill/ml Endometriosis Polycystic ovary syndrome Uterine disease ( polyps , myomas müllerian disease )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>intrauterine insemination</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>implantation</keyword>
</DOC>